These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15201419)

  • 1. Mars or venus--is sex a risk factor for recurrent venous thromboembolism?
    Elliott CG; Rubin LJ
    N Engl J Med; 2004 Jun; 350(25):2614-6. PubMed ID: 15201419
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Glynn RJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658125
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
    N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family history for venous thromboembolism and the risk for recurrence.
    Hron G; Eichinger S; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Stain M; Gartner V; Kyrle PA
    Am J Med; 2006 Jan; 119(1):50-3. PubMed ID: 16431184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
    N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Brotman DJ
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658124
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Huisman MV; van der Meer FJ; van Rooden CJ; Prins MH
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14645647
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Tran HA
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
    [No Abstract]   [Full Text] [Related]  

  • 10. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
    Kyrle PA; Minar E; Hirschl M; Bialonczyk C; Stain M; Schneider B; Weltermann A; Speiser W; Lechner K; Eichinger S
    N Engl J Med; 2000 Aug; 343(7):457-62. PubMed ID: 10950667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Malik V; Kupfer Y; Tessler S
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658127
    [No Abstract]   [Full Text] [Related]  

  • 12. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and gender issues and venous thromboembolism.
    Moores L; Bilello KL; Murin S
    Clin Chest Med; 2004 Jun; 25(2):281-97. PubMed ID: 15099889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin for venous thromboembolism - walking the dosing tightrope.
    Schafer AI
    N Engl J Med; 2003 Apr; 348(15):1478-80. PubMed ID: 12601074
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.
    Brill-Edwards P; Ginsberg JS; Gent M; Hirsh J; Burrows R; Kearon C; Geerts W; Kovacs M; Weitz JI; Robinson KS; Whittom R; Couture G;
    N Engl J Med; 2000 Nov; 343(20):1439-44. PubMed ID: 11078768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prophylaxis with warfarin for venous thromboembolism.
    Büller HR; Prins MH
    N Engl J Med; 2003 Aug; 349(7):702-4. PubMed ID: 12917308
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.
    Schulman S; Wåhlander K; Lundström T; Clason SB; Eriksson H;
    N Engl J Med; 2003 Oct; 349(18):1713-21. PubMed ID: 14585939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism].
    Schmidt B; Schellong S
    Med Klin (Munich); 2003 Aug; 98(8):447-52. PubMed ID: 12928810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent venous thromboembolism: quite harmless after all?
    Konstantinides SV
    Thromb Haemost; 2008 Apr; 99(4):655-6. PubMed ID: 18392321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.